# Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)

> **NCT00090168** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 435 (actual)

## Conditions studied

- Hypercholesterolemia
- Atherosclerotic Disease
- Coronary Disease

## Interventions

- **DRUG:** MK0653A , ezetimibe (+) simvastatin
- **DRUG:** Comparator: atorvastatin
- **DRUG:** Duration of Treatment: 6 weeks

## Key facts

- **NCT ID:** NCT00090168
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01-27
- **Primary completion:** 2004-10-20
- **Final completion:** 2004-11-10
- **Target enrollment:** 435 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00090168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00090168, "Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00090168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*